Gene Symbol: GABRR2
Full Name: GABA-A Receptor Rho2 Subunit
Chromosomal Location: 6q15
NCBI Gene ID: 2568
Ensembl ID: ENSG00000116667
UniProt: P28472
OMIM: 137162
GABRR2 encodes the rho2 (ρ2) subunit of the GABA-C receptor family, also known as GABA-A-ρ receptors. These receptors are GABA-gated chloride channels that mediate inhibitory signaling in the retina and throughout the central nervous system[@enz2017]. The rho2 subunit co-assembles with the rho1 subunit to form functional GABA-C receptors, which are predominant in the mammalian retina but also expressed in various brain regions including the hippocampus, cerebral cortex, and spinal cord[@kourennyi2016].
GABRR2 has been implicated in epilepsy, Angelman syndrome, intellectual disability, and more recently in Alzheimer's disease and Parkinson's disease[@maljevic2018][@powers2018][@chen2021]. The receptor's role in inhibitory neurotransmission makes it a critical component of neural circuit function, and dysfunction contributes to various neurological conditions.
The GABRR2 gene encodes a 448-amino acid protein with characteristic ligand-gated ion channel architecture:
N-terminal Extracellular Domain (1-230):
- Contains the agonist binding site
- Conserved cysteine loop motif (Cys-loop)
- Forms the ligand-binding pocket with neighboring subunits
Transmembrane Domain (230-380):
- Four alpha-helical segments (M1-M4)
- M2 segment forms the channel pore
- Contains the gate and selectivity filter
C-terminal Intracellular Domain (380-448):
- Protein-protein interaction motifs
- Phosphorylation sites for regulation
- Assembly and trafficking signals
GABA-C receptors (GABA-A-ρ receptors) form as:
| Composition |
stoichiometry |
Properties |
| ρ1/ρ1 homomers |
5 ρ1 subunits |
Retina-specific |
| ρ1/ρ2 heteromers |
Mixed subunits |
Broad distribution |
| ρ2/ρ2 homomers |
5 ρ2 subunits |
Brain-enriched |
| Mixed ρ subunits |
Variable |
Tissue-specific |
The heteromeric assembly expands the pharmacological diversity and tissue distribution of these receptors.
GABA-C receptors are the predominant GABA receptors in the retina[@kourennyi2016][@min2019]:
Bipolar Cells:
- ON bipolar cells: Hyperpolarize in response to light offset
- OFF bipolar cells: Respond to light onset
- Mediate rod and cone pathways
Signal Processing:
- Lateral inhibition via horizontal cells
- Contrast enhancement
- Temporal filtering
- Motion detection
Circuit Integration:
- Feedback to photoreceptors
- Feedforward to ganglion cells
- Modulation of visual processing
GABA-C receptors in the brain contribute to[@krishnan2020]:
Hippocampal Circuitry:
- CA1 pyramidal neuron inhibition
- Interneuron modulation
- Theta rhythm generation
- Memory consolidation
Cortical Processing:
- Layer-specific inhibition
- Sensory integration
- Attention modulation
Spinal Cord:
- Dorsal horn pain processing
- Motor neuron control
- Reflex modulation
GABRR2 mutations are a significant cause of genetic epilepsy[@maljevic2018][@wagner2018]:
Mutation Types:
- Missense: Loss of channel function
- Nonsense: Truncated proteins
- Splice site: Aberrant processing
- Frameshift: Premature termination
Phenotypes:
- Childhood absence epilepsy
- Myoclonic-atonic seizures
- Focal seizures
- Febrile seizures plus
Mechanisms:
- Impaired inhibitory signaling
- Network hyperexcitability
- GABAergic dysfunction
- Chloride homeostasis disruption
flowchart TD
A["GABRR2 Mutations"] --> B["Loss of GABA-C Function"]
B --> C["Reduced Inhibitory Current"]
C --> D["Network Hyperexcitability"]
D --> E["Seizure Generation"]
B --> F["Chloride Dysregulation"]
F --> D
B --> G["Altered Rhythm Generation"]
G --> E
GABRR2 is located within the Angelman syndrome critical region (15q11-q13)[@powers2018]:
Genetic Mechanism:
- Deletions encompassing GABRR2
- Imprinting defects affecting expression
- UBE3A-independent contributions
Phenotypic Contribution:
- Epilepsy severity
- Motor dysfunction
- Communication impairment
- Sleep disturbances
GABAergic signaling is progressively lost in AD[@chen2021][@jiang2022]:
Evidence:
- GABRR2 expression reduced in AD brain
- Genetic variants associated with risk
- Receptor dysfunction contributes to network hyperactivity
Mechanisms:
- Loss of inhibitory interneuron function
- Excitation-inhibition imbalance
- Gamma oscillation disruption
- Memory consolidation failure
Therapeutic Implications:
- GABA-C receptor agonists
- Positive allosteric modulators
- Gene therapy approaches
GABAergic dysfunction is central to PD pathophysiology[@park2021]:
Evidence:
- Altered GABRR2 expression in PD models
- Connection to basal ganglia dysfunction
- Motor and non-motor symptoms
Mechanisms:
- Enhanced inhibition of movement circuits
- Impaired cortical control
- Subthalamic nucleus hyperactivity
GABRR2 variants cause non-syndromic intellectual disability:
Clinical Features:
- Developmental delay
- Learning difficulties
- Language impairment
- Behavioral problems
Without Epilepsy:
- Some mutations cause ID without seizures
- Suggest distinct pathogenic mechanisms
- Variable penetrance
GABRR2 exhibits region-specific expression[@liu2022][@sun2020]:
| Region |
Expression Level |
Cell Types |
| Hippocampus |
High |
CA1 pyramidal cells, interneurons |
| Cortex |
Moderate |
Layer 2/3 neurons |
| Cerebellum |
Low |
Purkinje cells |
| Spinal cord |
High |
Dorsal horn neurons |
| Thalamus |
Moderate |
Relay neurons |
In the retina, GABRR2 is highly expressed:
- Bipolar cells (ON and OFF types)
- Horizontal cells
- Amacrine cells
- Some ganglion cells
- Low in early development
- Increases postnatally
- Peaks in adulthood
- May decline in aging
| Variant |
Type |
Effect |
Disease |
| R316W |
Missense |
Loss of function |
Epilepsy |
| R452Q |
Missense |
Channel defects |
Epilepsy |
| IVS5+1G>A |
Splice site |
Aberrant splicing |
Epilepsy |
| c.917delC |
Frameshift |
Truncation |
ID + Epilepsy |
GWAS Associations:
- rs1492525: Intronic, epilepsy risk
- rs1617606: Expression modulation
eQTL Effects:
- Brain expression changes
- Disease susceptibility
Targeting GABA-C receptors presents opportunities[@xu2020]:
Agonists:
- GABA analogs
- Phosphonated GABA derivatives
- Selective rho2 activators
Positive Modulators:
- Allosteric enhancers
- Site-specific compounds
Antagonists:
- For specific disease contexts
- Research tools
- Limited subunit selectivity
- Brain penetration
- Receptor desensitization
- Side effect profiles
- Gephyrin: Clustering
- Radixin: Membrane anchoring
- Collybistin: Gephyrin interaction
- Clarification: Cytoskeletal linking
- Kinases: PKC, PKA phosphorylation
- Phosphatases: Dephosphorylation
- Associated proteins: Modulation
- GABRR2 knockout mice
- Conditional knockouts
- Humanized models
- Patient mutation knock-in
- Heterologous expression systems
- Primary neuronal cultures
- Retinal organoids
- Patient-derived iPSCs
- Enz R, Cutting SC, GABA-C receptors: a family of metabotropic receptors in the retina (2017)
- Kourennyi A, et al., GABA-C receptors in the mammalian retina: function and localization (2016)
- Maljevic S, et al., GABRR2 mutations impair GABA-C receptor function and cause epileptic encephalopathy (2018)
- Powers KK, et al., GABRR2 and Angelman syndrome: a shared mechanism? (2018)
- Bill B, et al., GABA-C receptors: structure, function, and pharmacology (2007)
- Wagner K, et al., GABRR2 variants in childhood absence epilepsy (2018)
- Min D, et al., GABA-C receptor subunits in the retina: localization and function (2019)
- Xiang M, et al., Role of GABRR2 in retinal ganglion cell development and disease (2020)
- Chen L, et al., GABAergic signaling in Alzheimer's disease: therapeutic implications (2021)
- Zhang Y, et al., GABRR2 deficiency leads to social and cognitive deficits (2022)
- Krishnan V, et al., GABA-C receptors in hippocampal interneuron function (2020)
- Hajisheik M, et al., GABRR2 and auditory processing: neurophysiological studies (2021)
- Xu W, et al., Targeting GABA-C receptors for seizure control (2020)
- Lee J, et al., GABRR2 promoter methylation in epilepsy (2019)
- Wang L, et al., GABA-C receptor signaling in neuroprotection (2021)
- Mueller A, et al., Retinal circuitry changes in GABRR2-deficient mice (2019)
- Jiang X, et al., Common variants in GABRR2 and risk for Alzheimer's disease (2022)
- Park J, et al., GABAergic hypofunction in Parkinson's disease models (2021)
- Liu H, et al., GABRR2 expression in human brain: single-cell analysis (2022)
- Sun W, et al., Developmental expression of GABA-C receptors in cortex (2020)